Company Search:
Advanced Search
Sponsored Links
IBN SINA Pharmaceutical Industry Ltd Company Snapshot
IBN SINA Pharmaceutical Industry Ltd operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares IBN SINA Pharmaceutical Industry Ltd with three other pharmaceutical manufacturers in Asia: Orchid Pharma Ltd of INDIA (2020 sales of 5.08 billion Indian Rupees [US$69.50 million] ), YSP Southeast Asia Holding Bhd of MALAYSIA (297.06 million Malaysian Ringgits [US$72.92 million] ), and Panacea Biotec Ltd which is based in INDIA (5.39 billion Indian Rupees [US$73.71 million] of which 76% was Formulation).

Sales Analysis. IBN SINA Pharmaceutical Industry Ltd reported sales of 6.19 billion Bangladeshi Taka (US$74.30 million) for the fiscal year ending June of 2020. This represents an increase of 17.6% versus 2019, when the company's sales were 5.26 billion Bangladeshi Taka. Sales at IBN SINA Pharmaceutical Industry Ltd have increased during each of the previous five years (and since 2015, sales have increased a total of 96%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
IBN SINA Pharmaceutical Industry Ltd
  Stock Performance Chart for IBN SINA Pharmaceutical Industry Ltd
  Stock Data: Recent Stock Performance:
  Current Price (3/4/2021): 229.00
(Figures in Bangladeshi Taka)
1 Week -0.3%   13 Weeks -6.3%  
4 Weeks -2.7%   52 Weeks -2.3%  
IBN SINA Pharmaceutical Industry Ltd Key Data:
  Exchanges: OTH Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2020 Sales 6,191,628,639
(Year Ending Jan 2021).
Employees: N/A
  Currency: Bangladeshi Taka Market Cap: 7,154,790,583
  Fiscal Yr Ends: June Shares Outstanding: 31,243,627
  Share Type: ORDINARY Closely Held Shares:
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.